Psychedelic renaissance stories

Aug 5, 2026

Scientists Advance Understanding of Psychedelic Mechanisms Through New Research Tools and Theories

Researchers have developed engineered mouse models for studying psychedelic drug actions, proposed a new neurobiological theory called 'apical hypercontextualisation' to explain altered perception, and identified psychedelic candidates that may reduce side effects while maintaining therapeutic benefits.

Aug 5, 2026·3 sources

Jul 15, 2026

Eli Lilly nears deal to acquire psychedelic drugmaker AtaiBeckley

Eli Lilly is in advanced talks to acquire AtaiBeckley, a psychedelic medicine company, with a deal potentially announced this week. The acquisition underscores growing interest from major pharmaceutical companies in psychedelic therapies.

Jul 15, 2026·2 sources

Jun 22, 2026

Definium's LSD-Based Pill Reduces Depression Symptoms in Late-Stage Trial

Definium Therapeutics reported that a single dose of its LSD-based experimental pill significantly reduced symptoms of major depression in patients in a late-stage trial, sending shares higher. The data brings the drug closer to potential FDA approval.

Jun 22, 2026·2 sources

Top claims

▪Unlike its parent compound quipazine, VCU-1012 did not slow digestion when tested in mice, indicating a reduction in off-target gastrointestinal side effects.
▪VCU-1012 administration reduced anxiety in mice with chemotherapy-induced mood disturbances.
▪Under the apical hypercontextualisation model, basal dendrites process local, feature-specific inputs, while apical dendrites gather remote, contextual signals and expectations from distant cortical regions and the thalamus.

Subtopics

Neuroplasticity Psychedelic clinical research & trials Psychedelic harm reduction Eli Lilly LSD

Psychedelics for depression

Depression

Psychedelic policy & regulation

Related timelines

Psychedelic renaissance stories

Scientists Advance Understanding of Psychedelic Mechanisms Through New Research Tools and Theories

Eli Lilly nears deal to acquire psychedelic drugmaker AtaiBeckley

Definium's LSD-Based Pill Reduces Depression Symptoms in Late-Stage Trial

Related timelines

Crypto hacks

Iran War

US Congress

Venture capital funding

Strait of Hormuz blockage